On the other hand, while the mechanism of ATM in preventing bacterial infections is well-known and indirectly supported by previous experience with other viral pneumonias, chronic lung diseases, and inflammatory disorders [48], its use is not yet accepted in the treatment of COVID-19 due to lack of good quality clinical data. The gene discussed is ATM; the disease is COVID-19.